SAN DIEGO, CA--(Marketwired - August 22, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that at The San Francisco Money Show's Cannabis Investing Symposium, which the Company is sponsoring, Medical Marijuana, Inc. CEO Dr. Stuart Titus will speak to investors about current global cannabis industry trends, investment opportunities and how the Company's diversified portfolio of cannabis companies and brands are capitalizing on the current cannabis revolution.
The Cannabis Investing Symposium at the 35th annual Money Show San Francisco 2016, taking place from August 23-25 at the San Francisco Marriott Marquis, will specifically focus on helping investors identify and engage with cannabis companies that represent profitable investments.
"We're in the midst of a global cannabis revolution and I'm honored to have been invited to speak to investors at the Money Show about reasons to get involved in this fast-growing industry with limitless opportunities," said Dr. Titus. "The entire cannabis industry, including both marijuana and hemp, offers an incredible growth opportunity for investors and is helping people who suffer with debilitating conditions across the globe."
On Tuesday, August 23, at 12:50 p.m. and Thursday, August 25, at 9:00 a.m., Dr. Titus will present "Cannabis Investing 101." Dr. Titus will also be participating on a "Q&A with Cannabis Investing Experts" panel at the Symposium on Wednesday, August 24, at 4:15 p.m., which will include a discussion on investment opportunities in today's global markets. Other panel members include Michael Berger of MoneyShow.com, Jason Spatafora of MarijuanaStocks.com, and Matt Karnes of GreenWave Advisors, LLC.
Representatives from Medical Marijuana, Inc.'s Investor Relations team will also be available at the Company's booth #315 for sit-down meetings and questions.
For more information on the San Francisco Money Show, visit: http://sanfranciscomoneyshow.com/speakers/ and for Medical Marijuana, Inc. visit medicalmarijuanainc.com.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.